Autres langues Atreca, Inc.

Actions

BCEL

US04965G1094

Marché Fermé - OTC Markets Autres places de cotation 21:53:14 12/06/2024			Varia. 5j.	Varia. 1 janv.
0,09 ^USD	-2,85 %		-1,53 %	-31,82 %

04/06	Atreca, Inc. annonce la démission de Franklin Berger du conseil d'administration	CI
20/05	Immunome achète des anticorps à Atreca	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Atreca, Inc. Announces Resignation of Franklin Berger from the Board	04/06
Immunome Completes Purchase of Antibodies From Atreca	20/05
Immunome, Inc. completed the acquisition of Substantially all Assets of Atreca, Inc..	20/05
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BCEL, CTLT, NS, SCX	18/04
North American Morning Briefing : Stock Futures -2-	17/04
North American Morning Briefing : Traders Await -2-	10/04
Atreca, Inc.(OTCPK:BCEL) dropped from S&P TMI Index	21/03
Atreca, Inc.(OTCPK:BCEL) dropped from NASDAQ Composite Index	18/03
Atreca : Failure to Satisfy Listing Rule - Form 8-K	11/03
Atreca, Inc. Announces Board Resignations	06/02
BCEL Stock Alert: Halper Sadeh LLC Is Investigating Atreca, Inc.	26/12
Immunome Signs Asset Purchase Agreement for Acquisition of Antibody-Related Assets From Atreca	26/12
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome	26/12
Immunome, Inc. entered into an agreement to acquire Substantially all Assets of Atreca, Inc. for $12.5 million.	26/12
Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives	14/11
Atreca, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Atreca, Inc. to Continue Exploring Strategic Alternatives	14/11
Investors Remain Cautious Over Fed Moves, Setting Wall Street Up for Lower Open	20/10/23
Top Premarket Gainers	19/10/23
Intelligent Bio Solutions Inc. (NASDAQ: INBS): "Fingerprint Sweat Analysis: Revolutionizing Drug Screening with Speed and Precision" (JAGX, BCEL, CDIO)	13/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Atreca, Inc.

Actions

BCEL

US04965G1094

Autres langues

Filtres